🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Status
Unknown
Location
Kurume University Hospital
Start Date
2015-08
Trial ID
NCT02528019
Treatments Being Tested
A randomized, multi-center study evaluating MET409 (50 mg) alone or in comb...
Status
Unknown
Location
Metacrine Investigative Site
Start Date
2020-12-15
Trial ID
NCT04702490
Treatments Being Tested
This study aims at exploring the use of Dapagliflozin and Empagliflozin in ...
Status
Unknown
Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Start Date
2024-08
Trial ID
NCT06012266
Treatments Being Tested
This exploratory study will assess the efficacy of combined pioglitazone an...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-01-01
Trial ID
NCT06989723
Heart Failure (HF) in Australia affects 1-2% of the population. Heart failu...
Status
Terminated
Location
Royal Prince Alfred Hospital
Start Date
2022-10-01
Trial ID
NCT05129722
Treatments Being Tested
The co-administration of SGLT2 inhibitor and GLP-1 receptor agonist would b...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-01
Trial ID
NCT05140694
Treatments Being Tested
CREST-KT is a single-center, double-blinded, randomized trial of empagliflo...
Status
Terminated
Location
Duke University Medical Center
Start Date
2022-07-25
Trial ID
NCT04906213
Treatments Being Tested
To rule out the beneficial effect of SGLT2-I to reduce liver fat, and chang...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06668753
Treatments Being Tested
Background: Diabetes is common among American Indian people and diabetic k...
Status
Withdrawn
Location
NIDDK, Phoenix
Start Date
2017-05-27
Trial ID
NCT03173963
Treatments Being Tested
SAVE-Care (Sodium Glucose Cotransporter-2 inhibitors \[SGLT2i\] As Novel Go...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2026-07-01
Trial ID
NCT06674109
Treatments Being Tested